bupropion has been researched along with ibogaine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fryer, JD; Lukas, RJ | 1 |
| Beerepoot, P; Lam, VM; Salahpour, A | 1 |
2 other study(ies) available for bupropion and ibogaine
| Article | Year |
|---|---|
Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine.
Topics: Antidepressive Agents; Bupropion; Cell Line; Dopamine Uptake Inhibitors; Excitatory Amino Acid Antagonists; Humans; Ibogaine; Phencyclidine; Receptors, Nicotinic; Tumor Cells, Cultured | 1999 |
Pharmacological Chaperones of the Dopamine Transporter Rescue Dopamine Transporter Deficiency Syndrome Mutations in Heterologous Cells.
Topics: Amino Acid Substitution; Bupropion; Dopamine Plasma Membrane Transport Proteins; HEK293 Cells; Humans; Ibogaine; Molecular Chaperones; Mutation, Missense; Nervous System Diseases; Syndrome | 2016 |